ANTINORI, ARJE
 Distribuzione geografica
Continente #
NA - Nord America 464
EU - Europa 207
AS - Asia 124
SA - Sud America 13
AF - Africa 1
Totale 809
Nazione #
US - Stati Uniti d'America 460
SG - Singapore 78
IE - Irlanda 55
IT - Italia 44
SE - Svezia 35
CN - Cina 30
DE - Germania 22
BR - Brasile 13
UA - Ucraina 13
GB - Regno Unito 6
AT - Austria 5
FR - Francia 5
BE - Belgio 4
CA - Canada 4
FI - Finlandia 4
HK - Hong Kong 4
RU - Federazione Russa 4
IN - India 3
RO - Romania 2
VN - Vietnam 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
NL - Olanda 1
OM - Oman 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 809
Città #
Chandler 119
Singapore 62
Dublin 54
Ashburn 36
Jacksonville 31
Princeton 30
The Dalles 26
Ann Arbor 16
Boardman 14
Santa Clara 13
Altamura 12
Pescara 10
Wilmington 10
New York 9
Nanjing 7
Nuremberg 7
Los Angeles 6
Brussels 4
Chieti 4
Dearborn 4
Hong Kong 4
Washington 4
Frankfurt am Main 3
Vienna 3
Arnsberg 2
Augusta 2
Beijing 2
Changsha 2
Dong Ket 2
Edinburgh 2
Guangzhou 2
Helsinki 2
Lappeenranta 2
London 2
Monmouth Junction 2
Munich 2
Nanchang 2
Raviscanina 2
Rio de Janeiro 2
Rome 2
Shenyang 2
Tianjin 2
Toronto 2
Alexandria 1
Ameno 1
Ananindeua 1
Andover 1
Aprilia 1
Araci 1
Arapiraca 1
Atlanta 1
Baghdad 1
Baku 1
Bandar Seri Begawan 1
Bishkek 1
Boston 1
Brno 1
Brooklyn 1
Budapest 1
Carpina 1
Chennai 1
Concórdia 1
Dalian 1
Francavilla Al Mare 1
Goiânia 1
Haikou 1
Hebei 1
Houston 1
Jinan 1
Johannesburg 1
Lanciano 1
Limeira 1
Linfen 1
Mateus Leme 1
Montesilvano Marina 1
Mumbai 1
Muscat 1
Norwalk 1
Ottawa 1
Palhoça 1
Riga 1
Romola 1
San Francisco 1
Santo Anastácio 1
Sapucaia do Sul 1
Sesto San Giovanni 1
Shaoxing 1
Stockholm 1
Taipei 1
Tallinn 1
Tel Aviv 1
Terni 1
Zhengzhou 1
Totale 576
Nome #
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 88
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 87
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 76
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 72
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 69
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 69
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 68
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 65
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 63
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 60
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 57
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 45
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” 44
Totale 863
Categoria #
all - tutte 5.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 10 0
2020/202139 0 1 9 1 0 10 1 1 2 1 8 5
2021/202268 3 0 1 4 1 7 5 4 6 5 7 25
2022/2023283 19 41 16 38 21 46 11 28 42 3 11 7
2023/2024126 2 1 13 4 7 42 19 6 9 4 0 19
2024/2025243 9 57 35 5 10 30 17 17 13 18 32 0
Totale 863